Soichiro Ando

492 total citations
26 papers, 399 citations indexed

About

Soichiro Ando is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Soichiro Ando has authored 26 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Soichiro Ando's work include Lung Cancer Diagnosis and Treatment (5 papers), Influenza Virus Research Studies (3 papers) and Respiratory viral infections research (3 papers). Soichiro Ando is often cited by papers focused on Lung Cancer Diagnosis and Treatment (5 papers), Influenza Virus Research Studies (3 papers) and Respiratory viral infections research (3 papers). Soichiro Ando collaborates with scholars based in Japan, United States and China. Soichiro Ando's co-authors include Tomohiko Iida, Hideki Kimura, Takahiro Nakajima, Thomas J. Santoro, Hideki Kimura, Rodney C. Baker, Makoto Suzuki, Naomichi Iwai, Naoyoshi Yamamoto and Makoto Suzuki and has published in prestigious journals such as Cancer Letters, The Annals of Thoracic Surgery and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Soichiro Ando

26 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soichiro Ando Japan 11 150 102 76 57 49 26 399
D.J. Wood United States 10 311 2.1× 125 1.2× 180 2.4× 37 0.6× 47 1.0× 16 588
Jianjun Bi China 12 122 0.8× 60 0.6× 105 1.4× 31 0.5× 41 0.8× 40 352
Sandra Radenković Serbia 9 127 0.8× 57 0.6× 127 1.7× 114 2.0× 36 0.7× 17 453
Hong Jin China 16 336 2.2× 54 0.5× 53 0.7× 64 1.1× 41 0.8× 33 597
Shufen Cao United States 13 218 1.5× 102 1.0× 116 1.5× 52 0.9× 35 0.7× 43 503
Judong Luo China 11 256 1.7× 90 0.9× 126 1.7× 82 1.4× 63 1.3× 21 450
Ram P. Tiwari India 11 213 1.4× 37 0.4× 96 1.3× 75 1.3× 49 1.0× 14 474
Yukiko Namba Japan 10 115 0.8× 172 1.7× 98 1.3× 46 0.8× 25 0.5× 22 342
Kenji Miyazaki Japan 11 268 1.8× 51 0.5× 38 0.5× 83 1.5× 35 0.7× 36 483

Countries citing papers authored by Soichiro Ando

Since Specialization
Citations

This map shows the geographic impact of Soichiro Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soichiro Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soichiro Ando more than expected).

Fields of papers citing papers by Soichiro Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soichiro Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soichiro Ando. The network helps show where Soichiro Ando may publish in the future.

Co-authorship network of co-authors of Soichiro Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Soichiro Ando. A scholar is included among the top collaborators of Soichiro Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soichiro Ando. Soichiro Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ando, Soichiro. (2018). Effectiveness of quadrivalent influenza vaccine based on the test-negative control study in children during the 2016–2017 season. Journal of Infection and Chemotherapy. 24(10). 782–788. 10 indexed citations
3.
Kimura, Hideki, et al.. (2007). Indications for mediastinoscopy and comparison of lymph node dissections in candidates for lung cancer surgery. Lung Cancer. 56(3). 349–355. 9 indexed citations
4.
Nakajima, Takahiro, Makoto Suzuki, Soichiro Ando, et al.. (2006). Spontaneous regression of bone metastasis from renal cell carcinoma; A case report. BMC Cancer. 6(1). 11–11. 16 indexed citations
5.
Chen, Hong, Makoto Suzuki, Yohko Nakamura, et al.. (2006). Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer. Oncology Reports. 15(5). 1281–5. 30 indexed citations
6.
Suzuki, Makoto, Yohko Nakamura, Miki Ohira, et al.. (2005). Aberrant methylation of FBN2 in human non-small cell lung cancer. Lung Cancer. 50(1). 43–49. 43 indexed citations
7.
Suzuki, Makoto, Hisayuki Shigematsu, Soichiro Ando, et al.. (2005). Aberrant methylation: common in thymic carcinomas, rare in thymomas. Oncology Reports. 14(6). 1621–4. 22 indexed citations
8.
Suzuki, Makoto, Soichiro Ando, Tomohiko Iida, Takehiko Fujisawa, & Hideki Kimura. (2005). Multimodality therapy and significance of serum CYFRA21-1 for thymic carcinoma. Oncology Reports. 13(6). 1127–31. 6 indexed citations
9.
Baker, Rodney C., et al.. (2004). Arachidonoyl-phospholipid remodeling in proliferating murine T cells.. Lipids in Health and Disease. 3(1). 1–1. 57 indexed citations
10.
Ando, Soichiro, Makoto Suzuki, Naoyoshi Yamamoto, Tomohiko Iida, & Hideki Kimura. (2004). The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.. PubMed. 24(3b). 1941–6. 39 indexed citations
11.
Ando, Soichiro, et al.. (2003). The significance of tumour markers as an indication for mediastinoscopy in non‐small cell lung cancer. Respirology. 8(2). 163–167. 13 indexed citations
12.
Kimura, Hideki, Naomichi Iwai, Soichiro Ando, et al.. (2003). A prospective study of indications for mediastinoscopy in lung cancer with CT findings, tumor size, and tumor markers. The Annals of Thoracic Surgery. 75(6). 1734–1739. 21 indexed citations
13.
Ando, Soichiro, Hideki Kimura, Naomichi Iwai, Naotaka Yamamoto, & Tomohiko Iida. (2003). Positive reactions for both Cyfra21-1 and CA125 indicate worst prognosis in non-small cell lung cancer.. PubMed. 23(3C). 2869–74. 26 indexed citations
14.
Kobayashi, S & Soichiro Ando. (2000). Reactive Arthritis or Reiter''s Syndrome and B51-associated Seronegative Spondyloarthropathy. Internal Medicine. 39(2). 89–89. 8 indexed citations
15.
Ikeda, Keigo, Masakazu Matsushita, Soichiro Ando, et al.. (2000). A case of hypopituitarism and primary hypothyroidism associated with antiphospholipid syndrome.. Japanese Journal of Clinical Immunology. 23(1). 37–42. 1 indexed citations
16.
Abe, Yoshinao, et al.. (1998). RELATIVE BIOLOGICAL EFFECTS OF CARBON ION BEAMS ON MOUSE INTESTINAL CRYPTS. 10(1). 27–33. 1 indexed citations
17.
Ando, Soichiro, Kumie Nojima, Hideyuki J. Majima, et al.. (1998). Evidence for mRNA expression of vascular endothelial growth factor by X-ray irradiation in a lung squamous carcinoma cell line. Cancer Letters. 132(1-2). 75–80. 30 indexed citations
18.
Ogihara, Takeshi, Soichiro Ando, S Kobayashi, et al.. (1998). A case of intestinal Behçet’s disease in association with HLA-B27 and HLA-B51. 8(1). 89–92. 3 indexed citations
19.
Ogihara, Takeshi, Soichiro Ando, S Kobayashi, et al.. (1998). A case of intestinal Behçet’s disease in association with HLA-B27 and HLA-B51. 8(1). 89–92. 2 indexed citations
20.
Ando, Soichiro, et al.. (1993). Long chain fatty acid utilization of T-cells from autoimmune MRL-lpr/lpr mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1181(2). 141–147. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026